Qiagen N.V.
NOT FOUND
—
2026-04-22 10:12:13
www.qiagen.com
NYQ: QGEN
Explore Qiagen N.V. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
—
Current Price
NOT FOUND
52W High / Low
$57.81 / $38.8
Stock P/E
—
Book Value
$18.33
Dividend Yield
0.64%
ROCE
9.02%
ROE
11.57%
Face Value
—
EPS
—
Exp Qtr EPS
—
Sector
Healthcare
Industry
Diagnostics & Research
Employees
5,654
Beta
0.79
Debt / Equity
48.56
Current Ratio
3.9
Quick Ratio
3.31
Forward P/E
14.8
Price / Sales
4.03
Enterprise Value
$9.16 B
EV / EBITDA
12.58
EV / Revenue
4.38
Rating
Buy
Target Price
$55.46
EPS Forecast (FY)
—
Pros
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
- Strong operating margin profile.
- Net margin remains healthy.
- Meaningful dividend yield is available.
Cons
- Some data points may be missing or delayed because the source is not an official exchange feed.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Personalis, Inc. | $6.34 | — | $663.37 M | — | -29.9% | -35.02% | $11.5 / $3.09 | $2.55 |
| 2. | Revvity, Inc. | $93.89 | 28.42 | $10.54 B | 0.3% | 3.29% | 3.22% | $118.3 / $81.36 | $64.57 |
| 3. | Fulgent Genetics, Inc. | $16.18 | — | $481.31 M | — | -8.07% | -5.51% | $31.04 / $13.46 | $35.78 |
| 4. | Sotera Health Company | $16.28 | 59.4 | $4.63 B | — | 12.01% | 15.42% | $19.85 / $10.17 | $2.13 |
| 5. | BillionToOne, Inc. | $86.97 | 489.81 | $3.65 B | — | 2.74% | 2.3% | $138.7 / $61.96 | $10.48 |
| 6. | ICON Public Limited Company | $114.42 | 15.51 | $8.76 B | — | 8.66% | 6.27% | $211 / $66.57 | $122.25 |
| 7. | Danaher Corporation | $189.21 | 37.67 | $133.79 B | 0.82% | 6.12% | 7.05% | $242.8 / $180.03 | $74.32 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 540.42 M | 532.58 M | 533.54 M | 483.46 M | 521.2 M | — |
| Operating Profit | 121.88 M | 137.29 M | 135.97 M | 125.16 M | 141.16 M | — |
| Net Profit | 107.83 M | 130.04 M | 96.25 M | 90.76 M | 88.32 M | — |
| EPS in Rs | 0.52 | 0.63 | 0.47 | 0.44 | 0.43 | — |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 2.09 B | 1.98 B | 1.97 B | 2.14 B |
| Operating Profit | 520.31 M | 199.9 M | 445.25 M | 576.23 M |
| Net Profit | 424.88 M | 83.59 M | 341.3 M | 423.21 M |
| EPS in Rs | 2.06 | 0.41 | 1.66 | 2.05 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 6.28 B | 5.69 B | 6.12 B | 6.29 B |
| Total Liabilities | 2.5 B | 2.12 B | 2.31 B | 2.82 B |
| Equity | 3.78 B | 3.57 B | 3.81 B | 3.47 B |
| Current Assets | 2 B | 1.96 B | 2.15 B | 2.39 B |
| Current Liabilities | 512.14 M | 1.04 B | 1.08 B | 974.52 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 654.33 M | 673.55 M | 459.45 M | 715.26 M |
| Investing CF | -305.28 M | -249.23 M | -87.66 M | -726.76 M |
| Financing CF | -178.98 M | -422.9 M | -433.83 M | -125.8 M |
| Free CF | 447.2 M | 502.31 M | 296.65 M | 565.93 M |
| Capex | -207.13 M | -171.24 M | -162.8 M | -149.34 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 0.66% | -8.23% | — | — |
| Earnings Growth % | -75.51% | -19.35% | — | — |
| Profit Margin % | 4.23% | 17.37% | 19.76% | — |
| Operating Margin % | 10.11% | 22.66% | 26.91% | — |
| Gross Margin % | 48.9% | 62.77% | 64.65% | — |
| EBITDA Margin % | 18.62% | 35.04% | 36.39% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
| Ex Date | Dividend |
|---|---|
| 2025-07-02 | $0.25 |
| 2024-01-30 | $1.3577 |
Stock Splits
No stock split history available.